Regulatory function of CD4+CD25++ T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity

Regulatory T cells were investigated in early-onset (EO) and late-onset (LO) myasthenia gravis patients with anti-acetylcholine receptor antibody (AChR-MG). Alterations in PD-1 and PD-L1 on CD4+CD25++ (Treg) and responder T cells (Tresp, CD4+CD25−) were observed in LOMG patients. GITR was decreased...

Full description

Saved in:
Bibliographic Details
Main Authors: Alahgholi-Hajibehzad, Mahdi (Author) , Marx, Alexander (Author)
Format: Article (Journal)
Language:English
Published: 15 April 2015
In: Journal of neuroimmunology
Year: 2015, Volume: 281, Pages: 51-60
ISSN:1872-8421
DOI:10.1016/j.jneuroim.2015.03.008
Online Access:Verlag, Volltext: http://dx.doi.org/10.1016/j.jneuroim.2015.03.008
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0165572815000557
Get full text
Author Notes:Mahdi Alahgholi-Hajibehzad, Piraye Oflazer, Fikret Aysal, Hacer Durmuş, Yeşim Gülşen-Parman, Alexander Marx, Feza Deymeer, Güher Saruhan-Direskeneli
Description
Summary:Regulatory T cells were investigated in early-onset (EO) and late-onset (LO) myasthenia gravis patients with anti-acetylcholine receptor antibody (AChR-MG). Alterations in PD-1 and PD-L1 on CD4+CD25++ (Treg) and responder T cells (Tresp, CD4+CD25−) were observed in LOMG patients. GITR was decreased on CD4+CD25++ of all patients. Decrease of FOXP3 was associated with lower phosphorylation of STAT5.1,25-dihydroxyvitamin D3 (VitD3) increased suppression in co-culture with a stronger effect in patients by acting possibly both on cell groups. Changes in surface molecules and intracellular pathways contribute to the defects of Treg in non-thymomatous AChR-MG and VitD3 can have modulatory effects.
Item Description:Gesehen am 02.11.2017
Im Titel sind „+” und "++" hochgestellt
Physical Description:Online Resource
ISSN:1872-8421
DOI:10.1016/j.jneuroim.2015.03.008